Guidelines and definitions for research on epithelial-mesenchymal transition
Open accessThe DOI matches its Crossref record; 138 of the 139 references it cites were found in a registry or an index.
Abstract
Epithelial–mesenchymal transition (EMT) encompasses dynamic changes in cellular organization from epithelial to mesenchymal phenotypes, which leads to functional changes in cell migration and invasion. EMT occurs in a diverse range of physiological and pathological conditions and is driven by a conserved set of inducing signals, transcriptional regulators and downstream effectors. With over 5,700 publications indexed by Web of Science in 2019 alone, research on EMT is expanding rapidly. This growing interest warrants the need for a consensus among researchers when referring to and undertaking research on EMT. This Consensus Statement, mediated by ‘the EMT International Association’ (TEMTIA), is the outcome of a 2-year-long discussion among EMT researchers and aims to both clarify the nomenclature and provide definitions and guidelines for EMT research in future publications. We trust that these guidelines will help to reduce misunderstanding and misinterpretation of research data generated in various experimental models and to promote cross-disciplinary collaboration to identify and address key open questions in this research field. While recognizing the importance of maintaining diversity in experimental approaches and conceptual frameworks, we emphasize that lasting contributions of EMT research to increasing our understanding of developmental processes and combatting cancer and other diseases depend on the adoption of a unified terminology to describe EMT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“consistent with enhanced paracrine signaling from increased numbers of senescent neighbors and with established features of epithelial aging.23,25,32–35”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Epithelial-to-mesenchymal transition (EMT) is another potential mechanism of both intrinsic and acquired resistance to KRASG12C inhibitors.”
From The current state of the art and future trends in RAS-targeted cancer therapies (2022) · cites this paper as [114]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Expression of canonical EMT transcription factors, including Snai1/2, Zeb1/2, and Twist1, is observed in both contexts77.”
From Cell diversity and plasticity during atrioventricular heart valve EMTs (2023) · cites this paper as [77]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A major challenge in the field has been to reliably identify senescent cells in tissues and organs.23,25,32–35”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [34]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
Self-citationNew insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
Dongre, A., & Weinberg, R. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0080-4 · Cited by 3,876
Self-citationTwist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Self-citationCano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Self-citationEmerging Biological Principles of Metastasis
Lambert, A. W., Pattabiraman, D. R., & Weinberg, R. A. (2017) · Cell · doi:10.1016/j.cell.2016.11.037 · Cited by 3,067
Self-citationBatlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Yu, M., Bardia, A., Wittner, B. S., Stott, S. L., Smas, M. E., Ting, D. T., Isakoff, S. J., Ciciliano, J. C., Wells, M. N., Shah, A. M., et al. (2013) · Science · doi:10.1126/science.1228522 · Cited by 2,476
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Self-citationZheng, X., Carstens, J. L., Kim, J., Scheible, M., Kaye, J., Sugimoto, H., Wu, C.-C., LeBleu, V. S., & Kalluri, R. (2015) · Nature · doi:10.1038/nature16064 · Cited by 2,032
Self-citationFischer, K. R., Durrans, A., Lee, S., Sheng, J., Li, F., Wong, S. T. C., Choi, H., El Rayes, T., Ryu, S., Troeger, J., et al. (2015) · Nature · doi:10.1038/nature15748 · Cited by 1,791
Research works printed but not linked: 1
- Hay, E. D. in Epithelial–Mesenchymal Interactions: 18th Hahnemann Symposium (eds R. Fleischmajer & Billingham, R. E.) 31–35 (Williams and Wilkins, 1968).
Cited by
Items 801–900 of 1,001
Yetkin-Arik, B., Jansen, S. A., Varderidou‐Minasian, S., Westendorp, B., Skarp, K., Altelaar, M. A. F., Lindemans, C. A., & Lorenowicz, M. J. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03738-9 · Cited by 15
“EMT is an essential event during organ development, plays a key role in wound healing and tissue regeneration, and is important during cancer development and metastasis [61].”
BackgroundGui, S., Yu, W., Xie, J., Peng, L., Xiong, Y., Song, Z., Luo, H., Xiao, J., Yuan, S., & Cheng, Z. (2024) · Endocrine Connections · doi:10.1530/ec-24-0097 · Cited by 15
“This process is linked to the increased expression of vimentin and N-cadherin, accompanied by the concomitant decrease of E-cadherin, and contributes to increased invasiveness, dissemination to distant locations, metastatic colonization, cancer stemness, and chemoresistance (28, 29, 30).”
BackgroundEpithelial-Mesenchymal Transition in Chronic Rhinosinusitis
Choi, T., Ryu, S., Bae, J.-S., Yoo, S. H., & Mo, J. (2024) · Journal of rhinology · doi:10.18787/jr.2024.00022 · Cited by 15
Bioengineering nanomaterials for tumor therapy and anti-metastasis
Cheng, J., Pan, Y., Zou, J., Zhang, M., Zhu, Y., Liu, Y., & Chen, X. S. (2024) · Progress in Materials Science · doi:10.1016/j.pmatsci.2024.101375 · Cited by 15
Zhang, Z., Xu, H., He, J., Hu, Q., Liu, Y., Xu, Z., Lou, W., Wu, W., Zhang, L., Pu, N., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07330-8 · Cited by 15
Engineered Nanocatalyst‐Enabled Cheolesterol Depletion for Enhanced Tumor Piezocatalytic Therapy
Li, M., Zhou, Y., Chen, X., Chen, W., Yang, Y., Qian, C., Yang, L. F., Zhang, Y. Y., Zhang, Z., Wu, W. Z., et al. (2025) · Advanced Science · doi:10.1002/advs.202500967 · Cited by 15
SOX9 suppresses colon cancer via inhibiting epithelial-mesenchymal transition and SOX2 induction
Feng, Y., Zhu, N., Bedi, K., Li, J., Perera, C. D., Green, M. E., Assarzadegan, N., Zhai, Y., Liu, Q., Baladandayuthapani, V., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci184115 · Cited by 16
“Recently, EMT researchers proposed the term epithelial-mesenchymal plasticity (EMP) for the dynamic cell states (40).”
Landragin, C., Saichi, M., Laisné, M., Durand, A., Prompsy, P., Leclère, R., Mesple, J., Borgman, K. J. E., Trouchet, A., Faraldo, M. M., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02331-9 · Cited by 15
“…“enricher” function (Clus-terProfiler R package) on the top overexpressed genes by the pre-tumoral as compared to the LP/Avd clusters (avg_log 2 FC > 0.5, adjusted P 0.05), using the Hall-mark collection from the Molecular Signature Database (MSigDB) 21 available through the msigdbr R package.”
InfluentialZhang, B., Wang, Y., Li, H., Feng, L., Li, W., & Cheng, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00492 · Cited by 15
“In this study, we focused on biological processes involved in the EMT, considering a recent paper “Guidelines and definitions for research on epithelial–mesenchymal transition” (Yang et al., 2020), which authors put forward Consensus Statement about EMT and suggest use cellular properties together with a set of molecu…”
MethodAnalysis of immune subtypes across the epithelial-mesenchymal plasticity spectrum
Chakraborty, P., Chen, E., McMullen, I., Armstrong, A. J., Jolly, M. K., & Somarelli, J. A. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.06.023 · Cited by 15
EZH2 knockout in oral cavity basal epithelia causes more invasive squamous cell carcinomas
Baquero, J., Tang, X., Scognamiglio, T., & Gudas, L. J. (2021) · Carcinogenesis · doi:10.1093/carcin/bgab091 · Cited by 15
Wang, Q., Karvelsson, S. T., Jóhannsson, F., Vilhjálmsson, A. I., Hagen, L., Fonseca, D. D. M., Sharma, A., Slupphaug, G., & Rolfsson, Ó. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13172 · Cited by 15
The Scientific Rationale for the Introduction of Renalase in the Concept of Cardiac Fibrosis
Stojanović, D. R., Mitić, V., Stojanović, M., Milenković, J., Ignjatović, A., & Milojković, M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.845878 · Cited by 15
Guo, J., Xu, Y., Huang, Y., Li, Z., Ma, Q., Li, M., Zhao, Y., Li, B., & Tao, Y. (2022) · Current Cancer Drug Targets · doi:10.2174/1568009622666220705095403 · Cited by 15
Guo, Q., Xu, W., Li, X., Sun, J., Gu, X.-C., & Jing, F. (2022) · BioMed Research International · doi:10.1155/2022/7850658 · Cited by 15
“Epithelial-mesenchymal transition (EMT) refers to a wellestablished process that epithelial cells lose intercellular “selfdiscipline” and are provided with mesenchymal features [5].”
Zhan, F., Deng, Q., Chen, Z., Xie, C., Xiang, S., Qiu, S., Tian, L., Wu, C., Ou, Y., Chen, J., et al. (2022) · Cancer Science · doi:10.1111/cas.15551 · Cited by 15
Ciccone, V., Filippelli, A., Bacchella, C., Monzani, E., & Morbidelli, L. (2022) · Cancers · doi:10.3390/cancers14174240 · Cited by 15
“The expression of vimentin and αSMA (mesenchymal markers) and VE-cadherin (typical endothelial marker) was studied on HUVEC lysates.”
BackgroundInfluentialAdvances in the Biology, Detection Techniques, and Clinical Applications of Circulating Tumor Cells
Wu, S., Zhao, S., Cui, D., & Xie, J. (2022) · Journal of Oncology · doi:10.1155/2022/7149686 · Cited by 15
Cancer Stem Cells—The Insight into Non-Coding RNAs
Bryl, R., Piwócka, O., Kawka, E., Mozdziak, P. E., Kempisty, B., & Knopik-Skrocka, A. (2022) · Cells · doi:10.3390/cells11223699 · Cited by 15
Buhe, H., Ma, J., Ye, F.-Z., Song, C., Chen, X., Liu, Y., Huang, L., Han, X., Ma, L., & Saiyin, H. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-01035-w · Cited by 15
“Basal extrusion and EMT are hallmarks of metastatic cancer cells [26, 38].”
BackgroundMyo-Inositol Reverses TGF-β1-Induced EMT in MCF-10A Non-Tumorigenic Breast Cells
Monti, N., Dinicola, S., Querqui, A., Fabrizi, G., Fedeli, V., Gesualdi, L., Catizone, A., Unfer, V., & Bizzarri, M. (2023) · Cancers · doi:10.3390/cancers15082317 · Cited by 15
“Definitely, as recommended by the Consensus Statement on EMT, “whenever it is experimentally feasible, EMT should be assessed through the combination of cellular properties and multiple molecular markers” [27].”
BackgroundThe Multi-Faceted Nature of Renalase for Mitochondrial Dysfunction Improvement in Cardiac Disease
Stojanović, D. R., Stojanović, M., Milenković, J., Veličkov, A., Ignjatović, A., & Milojković, M. (2023) · Cells · doi:10.3390/cells12121607 · Cited by 15
Metge, B. J., Alsheikh, H. A., Chen, D., Elhamamsy, A. R., Hinshaw, D. C., Chen, B.-R., Sleckman, B. P., Samant, R. S., & Shevde, L. A. (2023) · npj Precision Oncology · doi:10.1038/s41698-023-00410-y · Cited by 15
Rapanotti, M. C., Cugini, E., Campione, E., Raimondo, C. D., Costanza, G., Rossi, P., Ferlosio, A., Bernardini, S., Orlandi, A., Luca, A. D., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411792 · Cited by 15
“We included the key players of the EMT, the genes coding for E-cadherin (CDH1) and N-cadherin (CDH2), which were involved in the “cadherin switch” during EMT [23,85], and the mesenchymal markers VIM (vimentin) and HFN1 (fibronectin), defined as the core of EMT [23,51,104].”
BackgroundLi, S., Wang, W., Yu, H., Zhang, S., Bi, W., Sun, S., Hong, B., Fang, Z., & Chen, X. (2023) · BMC Cancer · doi:10.1186/s12885-023-11580-0 · Cited by 15
“Epithelial cells acquire a mesenchymal phenotype during epithelial-mesenchymal transition, and recent studies have linked epithelial-mesenchymal transition to many cellular functions including genomic instability, cancer cell drug resistance, and metabolic adaptations [53].”
BackgroundRegulation of Epithelial–Mesenchymal Plasticity by the E3 Ubiquitin-Ligases in Cancer
Rodríguez-Alonso, A., Casas-Pais, A., Roca‐Lema, D., Graña, B., Romay, G., & Figueroa, A. (2020) · Cancers · doi:10.3390/cancers12113093 · Cited by 15
“Degradations of the physical barriers result in the acquisition of invasive capacity, further allowing dissemination to distant tissues [1,18,19].”
BackgroundSjöstedt, E., Kolnes, A. J., Olarescu, N. C., Mitsios, N., Hikmet, F., Sivertsson, Å., Lindskog, C., Øystese, K. A., Jørgensen, A. P., Bollerslev, J., et al. (2020) · Cancers · doi:10.3390/cancers13010114 · Cited by 15
“Epithelial-to-mesenchymal transition (EMT) is a process where the tumours lose their epithelial phenotype and develop mesenchymal characteristics [4,5].”
BackgroundYu, J., Wang, W., Liu, B., Gu, J., Chen, S., Cui, Y., & Sun, G. (2021) · Journal of Cancer · doi:10.7150/jca.45493 · Cited by 15
“Metastasis is the most important biological behavior of malignant cells, and EMT is crucial in the cancer invasion and metastasis [31, 32].”
BackgroundArginine methylation in the epithelial‐to‐mesenchymal transition
Qin, J., & Xu, J. (2021) · FEBS Journal · doi:10.1111/febs.16152 · Cited by 15
Xu, B., Jiang, J., Luo, T., Jiang, Z.-J., Liu, X., & Li, L. (2021) · Medicine · doi:10.1097/md.0000000000026762 · Cited by 15
“EMT is a physiological process involving the transformation of epithelial cells into stromal cells, which enhances the ability of invasion, metastasis and anti-apoptosis of various cells.([16]) This physiological process has 2 sides, different types of EMT can promote wound healing, tissue regeneration and fibrosis, w…”
BackgroundcircRNA-0002109 promotes glioma malignant progression via modulating the miR-129-5P/EMP2 axis
Xia, H., Liu, B., Shen, N.-X., Xue, J., Chen, S., Guo, H., & Zhou, X. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.11.011 · Cited by 15
“A large number of studies has shown that the migration and invasion activities of tumor cells are closely related to EMT.(45,46) Our data revealed that the expression levels of circRNA-0002109 or EMP2 affect the expression levels of EMT markers (such as E-cadherin, N-cadherin, Vimentin, Slug, and Snail), indicating th…”
BackgroundReemployment of Kupffer’s vesicle cells into axial and paraxial mesoderm via transdifferentiation
Ikeda, T., Inamori, K., Kawanishi, T., & Takeda, H. (2022) · Development Growth & Differentiation · doi:10.1111/dgd.12774 · Cited by 15
Wu, Y. P., Li, A., Chen, C., Zhang, F., Chen, L., & Zheng, X. W. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1229168 · Cited by 14
“EMT is a biological process where polarized epithelial cells downregulate epithelial characteristics and acquire a mesenchymal phenotype (56).”
BackgroundKnutsen, E., Sajib, S. D., Fiskaa, T., Lorens, J. B., Guðjónsson, Þ., Mælandsmo, G. M., Johansen, S., Seternes, O. M., & Perander, M. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1249895 · Cited by 14
Exploring Salivary Epithelial Dysfunction in Sjögren’s Disease
Noll, B. D., Beckman, M. F., Mougeot, F. B., & Mougeot, J.-L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094973 · Cited by 14
“Cells undergoing Type II EMT express several epithelial markers such as cytokeratin and CDH1, while simultaneously expressing markers with mesenchymal phenotypes such as alpha -smooth muscle actin [ α -SMA] and vimentin [57,60].”
BackgroundSun, Z., Li, X., Shi, Y., & Yao, Y. (2024) · Cancer Reports · doi:10.1002/cnr2.2085 · Cited by 14
Targeting Neuraminidase 4 Attenuates Kidney Fibrosis in Mice
Xiao, P., Hao, J., Kuang, Y., Dai, C. S., Rong, X., Jiang, L., Xie, Z., Zhang, L., Chen, Q., & Liu, E. (2024) · Advanced Science · doi:10.1002/advs.202406936 · Cited by 14
Sang, Y., & Qiao, L. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1462841 · Cited by 14
Vaping and tumor metastasis: current insights and progress
Xi, Y., Yang, L., Burtness, B. A., & Wang, H. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10221-7 · Cited by 14
“It involves the loss of cell polarity and downregulation of epithelial cell adhesion molecules, leading to enhanced migratory and invasive capabilities that facilitate metastasis in vivo [33, 34].”
Sui, X., Gao, B., Zhang, L., Wang, Y., Ma, J., Wu, X., Zhou, C., Liu, M., & Zhang, L. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-024-01570-6 · Cited by 14
Arjsri, P., Srisawad, K., Umsumarng, S., Thippraphan, P., Anuchapreeda, S., & Dejkriengkraikul, P. (2025) · Biomolecules · doi:10.3390/biom15010103 · Cited by 14
Targeting cancer cell stiffness and metastasis with clinical therapeutics
Gajda, A. M., Rodríguez-López, R., & Er, E. E. (2025) · Clinical & Experimental Metastasis · doi:10.1007/s10585-025-10353-2 · Cited by 14
“Softer cancer cells are also enriched in the expression of epithelial to mesenchymal transition (EMT) genes, which are associated with invasive and metastatic behavior [37, 38].”
Masters of adaptation: How cancer and immune cell plasticity mediates tumor progression
Rosenbaum, S. R., Fields, K. M., & Ford, H. L. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003301 · Cited by 14
“Cells may undergo a partial EMT, exhibiting various EMT-like features along a spectrum with the ability to adopt mixed features, also known as epithelial–mesenchymal plasticity, and a single tumor may contain a mix of cells in different hybrid EMT states [39].”
Self-citationThe versatile roles of retinal pigment epithelium in the pathophysiology of retinitis pigmentosa
Ghanawi, H., & Koch, S. (2025) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2025.101390 · Cited by 14
AKR1B10 dictates c-Myc stability to suppress colorectal cancer metastasis via PP2A nitration
Wu, X., Huang, S., Gao, J., Huang, S., Chen, L., Zhao, Z., Pu, R., Ma, X., Liu, X., He, W., et al. (2025) · Science Advances · doi:10.1126/sciadv.adv6937 · Cited by 14
Antibody-drug conjugates targeting the cadherin, claudin and nectin families of adhesion molecules
Katoh, M., Loriot, Y., Nakayama, I., Hamada, A., Shitara, K., & Katoh, M. (2025) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2025.1661016 · Cited by 14
Peng, Q., Shen, Y., Fu, K., Dai, Z., Jin, L., Yang, D., & Zhu, J. (2021) · Aging · doi:10.18632/aging.202594 · Cited by 14
EZH2 regulates the malignancy of human glioblastoma cells via modulation of Twist mRNA stability
Zhai, X., Li, L., Zhou, Y., Ji, W., Chen, H., Xiao, H., & Liang, P. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174177 · Cited by 14
Juste-Lanas, Y., Guerrero, P. E., Camacho-Gómez, D., Hervás-Raluy, S., García‐Aznar, J. M., & Gómez‐Benito, M. J. (2022) · Journal of Biomechanical Engineering · doi:10.1115/1.4053143 · Cited by 14
Feng, Q., Yang, P., Wang, H., Li, C., Hasegawa, T., Liu, Z., & Li, M. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.65824 · Cited by 14
“Several molecular markers are partially employed to judge the EMT progress [38].”
BackgroundSpatially Annotated Single Cell Sequencing for Unraveling Intratumor Heterogeneity
Smit, M. M., Feller, K. J., You, L., Storteboom, J., Begce, Y., Beerens, C. E. M. T., & Chien, M. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.829509 · Cited by 14
Hori, N., Takakura, Y., Sugino, A., Iwasawa, S., Nomizo, K., Yamaguchi, N., Takano, H., & Yamaguchi, N. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17279 · Cited by 14
Role of the E3 ubiquitin-ligase Hakai in intestinal inflammation and cancer bowel disease
Roca‐Lema, D., Quiroga, M., Khare, V., Díaz-Díaz, A., Barreiro-Alonso, A., Rodríguez-Alonso, A., Concha, Á., Romay, G., Cerdán, M. E., Gasché, C., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-22295-w · Cited by 14
Lee, M. H., Sung, K. E., Beebe, D. J., Huang, W., Shapiro, D., Miyamoto, S., & Abel, E. J. (2022) · Oncogenesis · doi:10.1038/s41389-022-00440-4 · Cited by 14
“5 SENP1 overexpression increases EMT-related proteins, invasion, and metastasis of ccRCC cells.”
BackgroundInfluentialBurger, G. A., Nesenberend, D., Lems, C. M., Hille, S. C., & Beltman, J. B. (2022) · Royal Society Open Science · doi:10.1098/rsos.220186 · Cited by 14
Fina, E. (2022) · Cancers · doi:10.3390/cancers14225668 · Cited by 14
Shao, W., Tsunematsu, T., Umeda, M., Tawara, H., Fujiwara, N., Mouri, Y., Arakaki, R., Ishimaru, N., & Kudo, Y. (2023) · Cancer Medicine · doi:10.1002/cam4.5601 · Cited by 14
Malgundkar, S. H., & Tamimi, Y. (2023) · Future Science OA · doi:10.2144/fsoa-2022-0032 · Cited by 14
Katipally, R. R., Pitroda, S. P., Weichselbaum, R. R., & Hellmän, S. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0376 · Cited by 14
Traberg, W. C., Uribe, J., Druet, V., Hama, A., Moysidou, C., Huerta, M., McCoy, R. S. A., Hayward, D., Savva, A., Genovese, A. M. R., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202301194 · Cited by 14
“Resistance of the cell layer is a quantitative measure of barrier integrity and permeability, and, as such, can be correlated to the EMT status of cells (Figure 1).”
BackgroundOvol1/2 loss‐induced epidermal defects elicit skin immune activation and alter global metabolism
Dragan, M., Chen, Z., Li, Y., Le, J., Sun, P., Haensel, D., Sureshchandra, S., Pham, A., Lu, E., Pham, K. T., et al. (2023) · EMBO Reports · doi:10.15252/embr.202256214 · Cited by 14
“…(i) Zeb1 , encoding an EMT-inducing transcription factor and a known direct target of Ovol2 repression (Watanabe et al , 2014; Lee et al , 2014a; Yang et al , 2020); (ii) genes with known association with membrane/cytoskeletal processes: Lix1l , Flot2 , Dennd5a , Ccdc88a , Cep170 , Sacs , and…”
Innate Immunity, Epithelial Plasticity, and Remodeling in Asthma
Brasier, A. R. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-32259-4_13 · Cited by 14
Wang, L., Wang, B., Kou, E., Du, L., & Zhu, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1259515 · Cited by 14
“fibroblast subset can originate from epithelial cells though the epithelial-to-mesenchymal transition (EMT) process (Figure 2) or the activation of normal fibroblasts under various inflammatory stimuli (30, 40, 41).”
BackgroundGohlke, L., Alahdab, A., Oberhofer, A., Worf, K., Holdenrieder, S., Michaelis, M., Cinatl, J. J., & Ritter, C. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914742 · Cited by 14
Everest‐Dass, A., Nersisyan, S. A., Maar, H., Novosad, V., Schröder‐Schwarz, J., Freytag, V., Stuke, J. L., Beine, M. C., Schiecke, A., Haider, M., et al. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13535 · Cited by 14
Hippo pathway in intestinal diseases: focusing on ferroptosis
Deng, H., Jia, Q., Ming, X., Sun, Y., Lu, Y., Liu, L., & Zhou, J. F. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1291686 · Cited by 14
Cooperative pro-tumorigenic adaptation to oncogenic RAS through epithelial-to-mesenchymal plasticity
Blander, H. D., Tonon, L., Fauvet, F., Pommier, R. M., Lamblot, C., Benhassoun, R., Angileri, F., Gibert, B., Rodriguez, R., Ouzounova, M., et al. (2024) · Science Advances · doi:10.1126/sciadv.adi1736 · Cited by 14
Self-citationInformation‐Distilled Generative Label‐Free Morphological Profiling Encodes Cellular Heterogeneity
Lo, M. C. K., Siu, D. M. D., Lee, K. C. M., Wong, J. S. J., Yeung, M. C. F., Hsin, M. K. Y., Ho, J., & Tsia, K. K. (2024) · Advanced Science · doi:10.1002/advs.202307591 · Cited by 14
“Despite there are currently no specific molecular markers can universally define the mesenchymal state in all EMT programs [28], fluorescence labels targeting EpCAM and Vim are broadly regarded as valuable markers indicative of EMP - a partial EMT during which cells express with a mixture of…”
BackgroundInfluentialPlunder, S., Danesin, C., Glise, B., Ferreira, M. A., Merino-Aceituno, S., & Théveneau, E. (2024) · Nature Communications · doi:10.1038/s41467-024-51372-z · Cited by 14
Santos‐Sousa, L., Pankonien, I., Simões, F. B., Chanson, M., & Amaral, M. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186717 · Cited by 14
“Indeed, KLF4 KO decreased the levels of E-Cad and cytokeratin 18 (CK18), which are commonly used as markers of epithelial cells, whilst increasing the levels of vimentin and Neural Cadherin (N-Cad), also commonly used as mesenchymal/EMT markers [40,41].”
BackgroundCellular plasticity in bone metastasis
Fang, C., & Kang, Y. (2020) · Bone · doi:10.1016/j.bone.2020.115693 · Cited by 14
Self-citationMarkov, A. V., Odarenko, K. V., Васильевна, С. А., Salomatina, O. V., Salakhutdinov, N. F., & Аркадьевна, З. М. (2020) · Molecules · doi:10.3390/molecules25245925 · Cited by 14
“These cells can secrete an array of growth factors and cytokines, such as transforming growth factor β (TGF-β), epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), interleukin 6 (IL-6) and others, which bind to the corresponding receptors exposed on the surface of tumor cells and thereby activate…”
BackgroundMethodInfluentialLanduzzi, L., Palladini, A., Ceccarelli, C., Asioli, S., Nicoletti, G., Giusti, V., Ruzzi, F., Ianzano, M. L., Scalambra, L., Laranga, R., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81085-y · Cited by 14
Ma, J., van der Zon, G., Sánchez‐Duffhues, G., & ten Dijke, P. (2021) · Journal of Visualized Experiments · doi:10.3791/62198 · Cited by 14
“In this regard, the EMT International Association (TEMTIA) strongly emphasizes the need of complementary techniques to ultimately demonstrate the occurrence of EMT/EndMT 11 .”
BackgroundMorgani, S. M., Su, J., Nichols, J., Massagué, J., & Hadjantonakis, A. (2021) · eLife · doi:10.7554/elife.64811 · Cited by 14
Self-citationXue, J., Bai, J., Long, Q., Wei, Y.-L., Pan, J., Li, X., & Tang, Q. (2021) · Aging · doi:10.18632/aging.203024 · Cited by 14
Viscoelasticity and cell swirling motion
Pajić‐Lijaković, I., & Milivojevic, M. S. (2022) · Advances in applied mechanics · doi:10.1016/bs.aams.2022.05.002 · Cited by 14
Kawami, M., Takenaka, S., Akai, M., Yumoto, R., & Takano, M. (2021) · Biomolecules · doi:10.3390/biom11121853 · Cited by 14
“In guidelines for research on EMT, several mesenchymal markers, such as α-SMA, N-cadherin, and vimentin are recommended as EMT indicators [18].”
BackgroundAltered microvasculature in pancreatic islets from subjects with type 1 diabetes
Granlund, L., Hedin, A., Korsgren, O., Skog, O., & Lundberg, M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0276942 · Cited by 14
“Epithelial mesenchymal transition (EMT) is a biological process where epithelial cells are transitioned to mesenchymal cells, and is, among other things, important during embryogenesis and organ development as well as wound healing [38].”
BackgroundCellular Plasticity and Heterotypic Interactions during Breast Morphogenesis and Cancer Initiation
Ingþórsson, S., Traustadóttir, G. Á., & Guðjónsson, Þ. (2022) · Cancers · doi:10.3390/cancers14215209 · Cited by 14
“However complete EMT is rarely seen in cancer, rather partial EMT (pEMT) is by most researchers considered a frequently occurring event [69].”
BackgroundCell diversity and plasticity during atrioventricular heart valve EMTs
Lotto, J., Cullum, R., Drissler, S., Arostegui, M., Garside, V. C., Fuglerud, B. M., Clement-Ranney, M., Thakur, A., Underhill, T. M., & Hoodless, P. A. (2023) · Nature Communications · doi:10.1038/s41467-023-41279-6 · Cited by 13
Huang, H., Li, T., Meng, Z., Zhang, X.-Q., Jiang, S., Suo, M., & Li, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713206 · Cited by 13
“During the EMT, epithelial properties are suppressed, and mesenchymal properties emerge through complex mechanisms, such as gene expression and post-translational regulation [6].”
BackgroundGenomic Landscape of Pulmonary Sarcomatoid Carcinoma
Kwon, H. J., Lee, S., Han, Y. B., Lee, J., Kwon, S., Kim, H., & Chung, J.-H. (2023) · Cancer Research and Treatment · doi:10.4143/crt.2023.764 · Cited by 13
“In cancer cells, mutations in any one of these transcription factors can lead to epithelial-mesenchymal plasticity, inducing an intermediate phenotype that can effectively induce cancer cells to invade, metastasize, and develop chemoresistance [5].”
Metge, B. J., Alsheikh, H. A., Kammerud, S. C., Chen, D., Das, D., Nebane, N. M., Bostwick, J. R., Shevde, L. A., & Samant, R. S. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06694-7 · Cited by 13
Zhang, J., Miao, G., Ta, M. H., Zhao, B., Wang, W., Xing, Y., Qian, H., Huang, D., Chen, W., & Zhong, Y. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.05.028 · Cited by 13
Faraldo, M. M., Romagnoli, M., Wallon, L., Dubus, P. R., Deugnier, M., & Fré, S. (2024) · Breast Cancer Research · doi:10.1186/s13058-024-01851-4 · Cited by 13
“This process implies the existence of intermediate cellular states displaying both epithelial and mesenchymal (E/M) traits, that have been correlated to increased tumorigenicity in different types of cancer (reviewed in [54, 55]).”
BackgroundJauvain, M., Lepied, G., Bénéjat, L., Roudier, N., Dussert, C., Lehours, P., Varon, C., & Bessède, E. (2024) · Helicobacter · doi:10.1111/hel.13108 · Cited by 13
USP5 promotes tumor progression by stabilizing SLUG in bladder cancer
Wan, Q., Li, T., Liu, B., & He, B. (2024) · Oncology Letters · doi:10.3892/ol.2024.14705 · Cited by 13
“Despite its recognized significance as a predictor of bladder cancer metastasis and its association with drug resistance, the precise underlying mechanisms of EMT in bladder cancer remain incompletely understood (21,22).”
BackgroundAlternative polyadenylation in cancer: Molecular mechanisms and clinical application
Zhang, Y., Huang, Z., Lu, W., & Liu, Z. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104599 · Cited by 14
Huang, X., Ali, A., Yachioui, D. E., Dévédec, S. E. L., & Hankemeier, T. (2025) · Progress in Lipid Research · doi:10.1016/j.plipres.2025.101330 · Cited by 13
Li, J., Long, S., Zhang, Y., Yu, S., Xu, H., Liang, R., Liu, Q., Zhang, J., Li, X., Fu, Y., et al. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02036-6 · Cited by 13
“We identified novel EMT-like subpopulations through unsupervised NMF clustering based on EMT pathway-related genes [41].”
Miyashita, N., Enokido, T., Horie, M., Fukuda, K., Urushiyama, H., Strell, C., Brunnström, H., Micke, P., Saito, A., & Nagase, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-01799-x · Cited by 13
Luo, J.-H., Zhang, X., & Sun, W.-H. (2022) · Aging · doi:10.18632/aging.204037 · Cited by 13
Skin epithelial cells change their mechanics and proliferation upon snail-mediated EMT signalling
Hosseini, K., Trus, P., Frenzel, A., Werner, C., & Fischer‐Friedrich, E. (2022) · Soft Matter · doi:10.1039/d2sm00159d · Cited by 13
Han, Z., Feng, Y., Deng, Y., Tang, Z., Cai, S., Zhuo, Y., Liang, Y., Ye, J., Cai, Z., Yang, S., et al. (2022) · Translational Andrology and Urology · doi:10.21037/tau-21-1148 · Cited by 13
“Besides, Slug and snail are core EMT transcription factors to serve central roles in the execution of EMT in many kinds of biological pathway, e.g., controlling cell–cell adhesion, cell migration and extracellular matrix (ECM) degradation (30).”
Zhang, X., Wang, H., Yu, M., Ma, K., & Li, N. (2022) · Translational Cancer Research · doi:10.21037/tcr-22-1736 · Cited by 13
Sikandar, S. S., Gulati, G. S., Antony, J., Fetter, I. J., Kuo, A. H., Ho, W. H. D., Acosta, V. H., Das, S., Steen, C. B., Pereira, T. A., et al. (2022) · Science Advances · doi:10.1126/sciadv.abm3548 · Cited by 13
Self-citationEvaluation of Epithelial–Mesenchymal Transition Markers in Autoimmune Thyroid Diseases
Sacristan-Gomez, P., Serrano-Somavilla, A., Castro-Espadas, L., de la Blanca, N. S., Sampedro-Nuñez, M. A., de Nova, J. L. M., Molina‐Jiménez, F., Rosell, A., Marazuela, M., & Martínez‐Hernández, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043359 · Cited by 13
“Type III is usually associated with cancer progression and inflammation [22,23].”
BackgroundRivière, É., Chivasso, C., Pascaud, J., Bechara, R., Ly, B., Delporte, C., Mariette, X., & Nocturne, G. (2023) · Clinical & Experimental Immunology · doi:10.1093/cei/uxad020 · Cited by 13
The Role of Tumor Epithelial-Mesenchymal Transition and Macrophage Crosstalk in Cancer Progression
May, A. M., Batoon, L., McCauley, L. K., & Keller, E. T. (2023) · Current Osteoporosis Reports · doi:10.1007/s11914-023-00780-z · Cited by 13
Metadata
- Authors
- Yang, J., Antin, P., Berx, G., Blanpain, C., Brabletz, T., Bronner, M., Campbell, K., Cano, A., Casanova, J., Christofori, G., Dedhar, S., Derynck, R., Ford, H. L., Fuxe, J., García de Herreros, A., Goodall, G. J., Hadjantonakis, A.-K., Huang, R. Y. J., Kalcheim, C., Kalluri, R., Kang, Y., Khew-Goodall, Y., Levine, H., Liu, J., Longmore, G. D., Mani, S. A., Massagué, J., Mayor, R., McClay, D., Mostov, K. E., Newgreen, D. F., Nieto, M. A., Puisieux, A., Runyan, R., Savagner, P., Stanger, B., Stemmler, M. P., Takahashi, Y., Takeichi, M., Theveneau, E., Thiery, J. P., Thompson, E. W., Weinberg, R. A., Williams, E. D., Xing, J., Zhou, B. P., Sheng, G., & On behalf of the EMT International Association (TEMTIA)
- Affiliations
- University of California San Diego (US)
- University of Arizona (US)
- Ghent University (BE)
- Université Libre de Bruxelles (BE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University of Sheffield (GB)
- Instituto de Investigaciones Biomédicas Sols-Morreale (ES)
- Consejo Superior de Investigaciones Científicas (ES)
- University of Basel (CH)
- University of British Columbia (CA)
- University of California, San Francisco (US)
- University of Colorado Anschutz (US)
- Karolinska University Hospital (SE)
- South Australia Pathology (AU)
- Memorial Sloan Kettering Cancer Center (US)
- National Taiwan University (TW)
- Hebrew University of Jerusalem (IL)
- The University of Texas MD Anderson Cancer Center (US)
- Princeton University (US)
- Northeastern University (US)
- Washington University in St. Louis (US)
- University College London (GB)
- Duke University (US)
- Royal Children's Hospital (AU)
- Instituto de Neurociencias (ES)
- Lyon 1 Université (FR)
- Inserm (FR)
- University of Pennsylvania (US)
- Kyoto University (JP)
- RIKEN Center for Biosystems Dynamics Research (JP)
- Guangzhou Regenerative Medicine and Health Guangdong Laboratory (CN)
- Translational Research Institute (AU)
- Whitehead Institute for Biomedical Research (US)
- Queensland University of Technology (AU)
- University of Pittsburgh (US)
- University of Kentucky (US)
- International Research Center for Medical Sciences, Kumamoto University (JP)
- Corresponding author
- Yang, Jing
- Sheng, Guojun
- ORCID
- Yang, Jing
- Antin, Parker
- Berx, Geert
- Blanpain, Cédric
- Brabletz, Thomas
- Campbell, Kyra
- Casanova, Jordi
- Christofori, Gerhard
- Dedhar, Shoukat
- Derynck, Rik
- Ford, Heide L.
- Fuxe, Jonas
- Goodall, Gregory J.
- Hadjantonakis, Anna-Katerina
- Huang, Ruby Y. J.
- Kalcheim, Chaya
- Kalluri, Raghu
- Kang, Yibin
- Levine, Herbert
- Liu, Jinsong
- Longmore, Gregory D.
- Mani, Sendurai A.
- Massagué, Joan
- Mayor, Roberto
- McClay, David
- Mostov, Keith E.
- Newgreen, Donald F.
- Nieto, M. Angela
- Puisieux, Alain
- Runyan, Raymond
- Savagner, Pierre
- Stanger, Ben
- Stemmler, Marc P.
- Takahashi, Yoshiko
- Takeichi, Masatoshi
- Theveneau, Eric
- Thiery, Jean Paul
- Thompson, Erik W.
- Weinberg, Robert A.
- Williams, Elizabeth D.
- Xing, Jianhua
- Zhou, Binhua P.
- Sheng, Guojun
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2020-04-16
- Volume
- 21
- Issue
- 6
- Pages
- 341-352
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- PMC
- PMC7250738
- OpenAlex
- W3016840787
- Cited by
- 2,226
- References
- 139
- Citations by year
- 2026: 249 · 2025: 382 · 2024: 403 · 2023: 396 · 2022: 386 · 2021: 313 · 2020: 88
- FWCI
- 32.46
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-10-15)
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by)
- QUT ePrints (Queensland University of Technology) (submittedVersion, cc-by)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, cc-by)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Biblos-e Archivo (Universidad Autónoma de Madrid) (submittedVersion, public-domain)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion, cc-by)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- Hispana (submittedVersion)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion, cc-by)
- Funders
- Wellcome Trust (204615/Z/16/Z)
- Biotechnology and Biological Sciences Research Council (BB/R00627X/1, BB/T013044/1)
- Japan Society for the Promotion of Science (19H04775, 20K21425, 18H02452, 20K20520, 16KT0071)
- National Cancer Institute (R01CA223758, R37CA232209, P30CA023100, P30CA016672)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK119232)
- National Institute of Environmental Health Sciences (P30ES006694)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P41HD088362)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- epithelial-mesenchymal transition, nomenclature, research guidelines, cell migration, cell invasion, transcription factors, cancer, developmental processes
- MeSH terms
- Cell Plasticity, Animals, Cell Movement, Humans, Neoplasms, Terminology as Topic, Developmental Biology, Consensus, Biomedical Research, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.